North Fourth Asset Management, LP Mannkind Corp Transaction History

North Fourth Asset Management, LP

  • $163 Million
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$1.79 - $4.04 $152,071 - $343,222
-84,956 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$1.56 - $2.08 $626,372 - $835,163
-401,521 Reduced 82.54%
84,956 $160,000
Q2 2020

Aug 14, 2020
BUY
$0.94 - $2.21 $457,288 - $1.08 Million
486,477 New
486,477 $851,000

Others Institutions Holding MNKD

# of Institutions
220
Shares Held
133M
Call Options Held
1.43M
Put Options Held
851K
View Full List

About MANNKIND CORP

MNKD Quotes by TradingView
  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.65B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track North Fourth Asset Management, LP Portfolio

Follow North Fourth Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Fourth Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on North Fourth Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email